DARI COOK-MCGIBBON: Open Payments
NPI 1639695752 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 44 payments from 19 companies in 2025. Trend: 2023 $401 · 2024 $970 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 7 | $130 |
| PFIZER INC. | 6 | $116 |
| Lundbeck LLC | 4 | $91 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Amgen Inc. | 3 | $45 |
| Verona Pharma, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $28 |
Products named: Dexcom G6 Transmitter, REXULTI, TRELEGY ELLIPTA, ELIQUIS, ZENPEP, EVENITY, PAXLOVID, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
